Advertisement
Advertisement

CRDL

CRDL logo

Cardiol Therapeutics Inc. Class A Common Shares

1.42
USD
Sponsored
+0.06
+4.41%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

1.41

-0.01
-0.85%

Cardiol Therapeutics Inc. Class A Common Shares Profile

About

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

Info & Links

CEO

David Elsley

Headquarters

2265 UPPER MIDDLE ROAD EAST, SUITE 602
OAKVILLE, A6 L6H 0G5, CANADA

Industry

Medical Drugs

Sector

Medical

Website

www.cardiolrx.com

Auditor

BDO Canada LLP

Share holders

--

Employees

18

Cardiol Therapeutics Inc. Class A Common Shares Statistics

Valuation Measures

Market Capitalization2

162.30M

Enterprise Value

142.22M

Enterprise Value/EBITDA(ttm)

-6.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.00

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-229.43%

Return on Invested Capital(ttm)

-238.40%

Return on Assets(ttm)

-165.60%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-23.13M

Net Income Available to Common(ttm)

-23.80M

Diluted EPS(ttm)

-0.28

Share Statistics

Beta (5Y Monthly)

0.72

52-Week Change

31.48%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

109.80M

% Held by Insiders

5.25%

% Held by Institutions

12.49%

Balance Sheet

Total Cash(mrq)

20.17M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

84.80K

Total Debt/Equity(mrq)

0.48%

Current Ratio(mrq)

4.39%

Quick Ratio(mrq)

4.39%

Book Value Per Share(mrq)

0.16

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.05

Free Cash Flow(ytd)

-5.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement